Phase 2 Clinical Trials

Browse Phase 2 clinical trials. AI-powered analysis of Phase 2 studies with plain English summaries and decoded eligibility.

Phase 2 Study of Systemic IL-6 Receptor Antagonist ACTEMRA® (Tocilizumab) for the Treatment of Progressive/Recurrent Pediatric Adamantinomatous Craniopharyngioma

NCT05233397 · RECRUITING · Phase 2 · Nationwide Children's Hospital

Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, 24-Week Study With Additional 24-Week Blinded Active Extension to Evaluate the Safety and Efficacy of COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

NCT07161999 · RECRUITING · Phase 2 · Coya Therapeutics

The Effect of Venlafaxine as an Adjunct Therapy on The Clinical Outcome of Rheumatoid Arthritis Patients

NCT07497282 · NOT YET RECRUITING · Phase 2 · Ain Shams University

Randomized Phase II Trial of Encorafenib and Cetuximab With or Without Nivolumab (NSC #748726) for Patients With Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer

NCT05308446 · ACTIVE NOT RECRUITING · Phase 2 · National Cancer Institute (NCI)

Phase 1B/2A Study of CTO1681 for the Prevention and Treatment of Cytokine Release Syndrome in Patients With Diffuse Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy

NCT05905328 · RECRUITING · Phase 2 · CytoAgents, Inc.

Low-Dose Ketamine Infusion for the Treatment of Multiple Sclerosis Fatigue (INKLING-MS)

NCT05378100 · ACTIVE NOT RECRUITING · Phase 2 · Johns Hopkins University

An Open-Label, Exploratory, Phase 2 Scintigraphy Study Evaluating 18F mFBG for Imaging Myocardial Sympathetic Innervation in Subjects With Heart Failure and Implantable Cardioverter-Defibrillators

NCT06965621 · NOT YET RECRUITING · Phase 2 · Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)

A Clinical Trial to Evaluate the Long-term Safety and Durability of Efficacy of BI 3720931, an Inhaled Lentiviral Vector Gene Therapy, After Single Dose Administration in a Previous Clinical Trial, in People With Cystic Fibrosis Rolled-over From a Previous Clinical Trial With BI 3720931 (Lenticlair™-ON)

NCT06962852 · ACTIVE NOT RECRUITING · Phase 2 · Boehringer Ingelheim

The Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques: An Investigator-Blinded Study

NCT02784210 · RECRUITING · Phase 2 · National Institute of Neurological Disorders and Stroke (NINDS)

A Phase IIa Double-Blind, Randomized, Parallel-Arm, Placebo-Controlled Trial To Investigate The Effects Of Three Dose Levels Of CIT-013 On Disease Activity In Patients With Moderately Active Rheumatoid Arthritis.

NCT06567470 · RECRUITING · Phase 2 · Citryll BV

Other Phases